![PDF) ASPIRE trial: study protocol for a double-blind randomised controlled trial of aspirin for overheating during exercise in multiple sclerosis PDF) ASPIRE trial: study protocol for a double-blind randomised controlled trial of aspirin for overheating during exercise in multiple sclerosis](https://i1.rgstatic.net/publication/345943346_ASPIRE_trial_study_protocol_for_a_double-blind_randomised_controlled_trial_of_aspirin_for_overheating_during_exercise_in_multiple_sclerosis/links/60194c3e299bf1b33e40bbbb/largepreview.png)
PDF) ASPIRE trial: study protocol for a double-blind randomised controlled trial of aspirin for overheating during exercise in multiple sclerosis
Nonregistration, discontinuation, and nonpublication of randomized trials: A repeated metaresearch analysis | PLOS Medicine
![Rationale and design of repeated cross-sectional studies to evaluate the reporting quality of trial protocols: the Adherence to SPIrit REcommendations (ASPIRE) study and associated projects | Trials | Full Text Rationale and design of repeated cross-sectional studies to evaluate the reporting quality of trial protocols: the Adherence to SPIrit REcommendations (ASPIRE) study and associated projects | Trials | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13063-020-04808-y/MediaObjects/13063_2020_4808_Fig1_HTML.png)
Rationale and design of repeated cross-sectional studies to evaluate the reporting quality of trial protocols: the Adherence to SPIrit REcommendations (ASPIRE) study and associated projects | Trials | Full Text
![Dolutegravir plus lamivudine maintains HIV-1 suppression through week 48 in a pilot randomized trial (ASPIRE) Dolutegravir plus lamivudine maintains HIV-1 suppression through week 48 in a pilot randomized trial (ASPIRE)](https://www.natap.org/2017/images/110817/110817-5/1108171.gif)
Dolutegravir plus lamivudine maintains HIV-1 suppression through week 48 in a pilot randomized trial (ASPIRE)
![Vaginal ring provides partial protection from HIV in large multinational trial | National Institutes of Health (NIH) Vaginal ring provides partial protection from HIV in large multinational trial | National Institutes of Health (NIH)](https://www.nih.gov/sites/default/files/styles/featured_media_breakpoint-medium/public/news-events/news-releases/2016/20160222-ring.jpg?itok=rHmiE5X6×tamp=1456176919)
Vaginal ring provides partial protection from HIV in large multinational trial | National Institutes of Health (NIH)
![ASPIRE trial: study protocol for a double-blind randomised controlled trial of aspirin for overheating during exercise in multiple sclerosis | BMJ Open ASPIRE trial: study protocol for a double-blind randomised controlled trial of aspirin for overheating during exercise in multiple sclerosis | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/10/11/e039691/F1.medium.gif)
ASPIRE trial: study protocol for a double-blind randomised controlled trial of aspirin for overheating during exercise in multiple sclerosis | BMJ Open
![Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trial - The Lancet Haematology Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trial - The Lancet Haematology](https://www.thelancet.com/cms/attachment/a50f7d53-23d5-44b4-8478-d5afbad96448/gr1_lrg.gif)
Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trial - The Lancet Haematology
![PPT - Aspirin for the prevention of recurrent venous thromboembolism (VTE) after a first PowerPoint Presentation - ID:6798704 PPT - Aspirin for the prevention of recurrent venous thromboembolism (VTE) after a first PowerPoint Presentation - ID:6798704](https://image3.slideserve.com/6798704/aspire-trial-design-l.jpg)